Tumor necrosis factor-α induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes

Cardiovascular Research

Volumn 45, Issue 3, 2000, Pages 595-602

  Song, Wei ^a   Lu, Xiangru ^a   Feng, Qingping ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Apoptosis; Myocytes; Nitric oxide

Indexed keywords

NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INDUCTION; HEART MUSCLE CELL; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELLS, CULTURED; DNA FRAGMENTATION; ENZYME INDUCTION; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICROSCOPY, ELECTRON; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033980347     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00395-8     Document Type: Article

References (32)

1. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
2. Yeh E.T.H. Life and death in the cardiovascular system. Circulation. 95:1997;782-786.
3. Haunstetter A., Izumo S. Apoptosis: Basic mechanisms and implications for cardiovascular disease. Circ Res. 82:1998;1111-1129.
4. Kelly R.A., Balligand J.L., Smith T.W. Nitric oxide and cardiac function. Circ Res. 79:1996;363-380.
5. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 43:1991;109-142.
6. Ishiyama S., Hiroe M., Nishikawa T., et al. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation. 95:1997;489-496.
7. Wildhirt S.M., Suzuki H., Horstman D., et al. Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction. Circulation. 96:1997;1616-1623.
8. Shimojo T., Hiroe M., Ishiyama S., Ito H., Nishikawa T., Marumo F. Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway. Exp Cell Res. 247:1999;38-47.
9. Albina J.E., Cui S., Mateo R.B., Reichner J.S. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol. 150:1993;5080-5085.
10. Fukuo K., Inoue T., Morimoto S., et al. Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques. J Clin Invest. 95:1995;669-676.
11. Fukuo K., Hata S., Suhara T., et al. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension. 27:1996;823-826.
12. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA. 92:1995;7162-7166.
13. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol. 274:1998;R577-R595.
14. Irwin M.W., Mak S., Mann D.L., et al. Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium. Circulation. 99:1999;1492-1498.
15. Habib F.M., Springall D.R., Davies G.J., Oakley C.M., Yacoub M.H., Polak J.M. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 347:1996;1151-1155.
16. Krown K.A., Page M.T., Nguyen C., et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 98:1996;2854-2865.
17. Ing D.J., Zang J., Dzau V.J., Webster K.A., Bishopric N.H. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res. 84:1999;21-33.
18. Pinsky D.J., Cai B., Yang X., Rodriguez C., Sciacca R.R., Cannon P.J. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide antagonism or transforming growth factor beta. J Clin Invest. 95:1995;677-685.
19. Kinugawa K., Shimizu T., Yao A., Kohmoto O., Serizawa T., Takahashi T. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ Res. 81:1997;911-921.
20. Muller-Werdan U., Schumann H., Fuchs R., et al. Tumor necrosis factor alpha (TNFα) is cardiodepressant in pathophysiologically relevant concentrations without inducing inducible nitric oxide-(NO)-synthase (iNOS) or triggering serious cytotoxicity. J Mol Cell Cardiol. 29:1997;2915-2923.
21. Haupt W., Zirngibl H., Stehr A., Riese J., Holzheimer R.G., Hohenberger W. Tumour necrosis factor-alpha and interleukin-10 production in septic patients and the regulatory effect of plasma. Eur J Surg. 165:1999;95-100.
22. Meldrum D.R., Dinarello C.A., Shames B.D., et al. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning. Circulation. 98:1998;II214-218.
23. Ito H., Hirata Y., Hiroe M., et al. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res. 69:1991;209-215.
24. Simmons W.W., Closs E.I., Cunningham J.M., Smith T.W., Kelly R.A. Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B. J Biol Chem. 271:1996;11694-11702.
25. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidiunium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
26. Laubach V.E., Shesely E.G., Smithies O., Sherman P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA. 92:1995;10688-10692.
27. Wong H., Anderson W.D., Cheng T., Riabowol K.T. Monitoring mRNA expression by polymerase chain reaction: The 'primer-dropping' method. Anal Biochem. 223:1994;251-258.
28. Grisham M.G., Johnson G.G., Gautreaux D.M., Berg R.D. Measurement of nitrate and nitrite in extracellular fluids: A window to systemic nitric oxide metabolism. Methods. 7:1995;84-90.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
30. Feng Q, Hedner T. Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO) I and II Physiology, pharmacology and pathophysiological implications. Clin Physiol 1990;10:407-426, 503-426.
31. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl J Med. 323:1990;236-241.
32. Feng Q., Fortin A.J., Lu X., Arnold J.M.O. Effects of L-arginine on endothelial and cardiac function in rats with heart failure. Eur J Pharmacol. 376:1999;37-44.